Streetbeat News

Analyst Ratings

FUSN

Oppenheimer analyst Jeff Jones has initiated coverage on Fusion Pharmaceuticals (NASDAQ:FUSN) with an Outperform rating and a price target of $13.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 9:02 am

BRK

Edward Jones analyst James Shanahan has downgraded Berkshire Hathaway Inc. Common Stock (NYSE:BRK) from Buy to Hold.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 8:56 am

BTE

BMO Capital analyst Mike Murphy has upgraded Baytex Energy (TSX:BTE) from Market Perform to Outperform and raised the price target from C$5.5 to C$7.5.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 8:51 am

EDIT

Stifel analyst Dae Gon Ha has upgraded Editas Medicine (NASDAQ:EDIT) from Hold to Buy and raised the price target from $9 to $17.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 8:45 am

VZIO

Barrington Research analyst James Goss has reiterated an 'Outperform' rating on VIZIO Holding (NYSE:VZIO) and maintained a $13 price target.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 8:37 am

ACN

Piper Sandler analyst Arvind Ramnani has maintained a Neutral rating on Accenture (NYSE:ACN) and lowered the price target from $312 to $300.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 8:32 am

NCNO

Piper Sandler analyst Brent Bracelin has reiterated a Neutral rating on Ncino (NASDAQ:NCNO) and maintained a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 8:28 am

INTU

Piper Sandler analyst Arvind Ramnani has reiterated an Overweight rating on Intuit (NASDAQ:INTU) and maintained a price target of $642.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 8:20 am

SSYS

Needham analyst James Ricchiuti has maintained a 'Buy' rating on Stratasys (NASDAQ:SSYS) but lowered the price target from $19 to $17.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 8:18 am

CCL

Carnival Corporation (NYSE:CCL) is expected to report a Q3 profit with earnings of 75 cents per share, compared to a loss of 58 cents per share in the previous year. The company's revenue is projected to be $6.69 billion, up from $4.9 billion in the year-ago period. Several analysts have recently adjusted their price targets for the company, with changes ranging from a decrease to $21 to an increase to $23.

Portfolio Pulse from Lisa Levin

September 29, 2023 | 6:24 am